Erratum: Effects of Saccharomyces boulardii on Neonatal Hyperbilirubinemia: A Randomized Controlled Trial(American Journal of Perinatology (2014) DOI: 10.1055/s-0034-1376390);Effects of Saccharomyces boulardii on neonatal hyperbilirubinemia: A randomized controlled trial

American Journal of Perinatology

Volumn 30, Issue 2, 2014, Pages 137-142

  Serce, Ozge ^a   Gursoy, Tugba ^a   Ovali, Fahri ^a   Karatekin, Guner ^a  

^a Zeynep Kamil Maternity and Child Research and Training Hospital   (Turkey)

Author keywords

neonatal hyperbilirubinemia; phototherapy; probiotic; Saccharomyces boulardii

Indexed keywords

BILIRUBIN; PROBIOTIC AGENT;

ADULT; BLOOD; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; FEMALE; HUMAN; HYPERBILIRUBINEMIA, NEONATAL; MALE; MULTIMODALITY CANCER THERAPY; NEWBORN; PHOTOTHERAPY; PREGNANCY; RANDOMIZED CONTROLLED TRIAL; SACCHAROMYCES; TREATMENT OUTCOME; YOUNG ADULT;

ADULT; BILIRUBIN; COMBINED MODALITY THERAPY; DOUBLE-BLIND METHOD; FEMALE; HUMANS; HYPERBILIRUBINEMIA, NEONATAL; INFANT, NEWBORN; MALE; PHOTOTHERAPY; PREGNANCY; PROBIOTICS; SACCHAROMYCES; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84939882794     PISSN: 07351631     EISSN: 10988785     Source Type: Journal    
DOI: 10.1055/s-0034-1389078     Document Type: Erratum

References (25)

1. Sgro M., Campbell D., Shah V. Incidence and causes of severe neonatal hyperbilirubinemia in Canada. CMAJ: 2006; 175 6 587 590
2. Bhutani V. K., Johnson L. H. Urgent clinical need for accurate and precise bilirubin measurements in the United States to prevent kernicterus. Clin Chem: 2004; 50 3 477 480
3. Bhutani V. K., Johnson L. H., Keren R. Diagnosis and management of hyperbilirubinemia in the term neonate: for a safer first week. Pediatr Clin North Am: 2004; 51 4 843 861, vii
4. Bhutani V. K., Johnson L., Sivieri E. M. Predictive ability of a predischarge hour-specific serum bilirubin for subsequent significant hyperbilirubinemia in healthy term and near-term newborns. Pediatrics: 1999; 103 1 6 14
5. Ip S., Chung M., Kulig J., et al. American Academy of Pediatrics Subcommittee on Hyperbilirubinemia. An evidence-based review of important issues concerning neonatal hyperbilirubinemia. Pediatrics: 2004; 114 1 e130 e153
6. Joint Commission on Accreditation of Healthcare Organizations Kernicterus threatens healthy newborns. Sentinel Event Alert: 2001; 18 1 4
7. Bisceglia M., Indrio F., Riezzo G., Poerio V., Corapi U., Raimondi F. The effect of prebiotics in the management of neonatal hyperbilirubinaemia. Acta Paediatr: 2009; 98 10 1579 1581
8. Burke B. L., Robbins J. M., Bird T. M., Hobbs C. A., Nesmith C., Tilford J. M. Trends in hospitalizations for neonatal jaundice and kernicterus in the United States, 1988-2005. Pediatrics: 2009; 123 2 524 532
9. Havenaar R., Huis in't Veld J. HJ. Probiotics: a general view. In: Wood B. JB., ed. The Lactic Acid Bacteria in Health and Disease. The Lactic Acid Bacteria Vol. 1. New York, NY Chapman and Hall: 1992; 209 224
10. Husebye E., Hellström P. M., Sundler F., Chen J., Midtvedt T. Influence of microbial species on small intestinal myoelectric activity and transit in germ-free rats. Am J Physiol Gastrointest Liver Physiol: 2001; 280 3 G368 G380
11. Banasaz M., Norin E., Holma R., Midtvedt T. Increased enterocyte production in gnotobiotic rats mono-associated with Lactobacillus rhamnosus GG. Appl Environ Microbiol: 2002; 68 6 3031 3034
12. van Meer H., Boehm G., Stellaard F., et al. Prebiotic oligosaccharides and the enterohepatic circulation of bile salts in rats. Am J Physiol Gastrointest Liver Physiol: 2008; 294 2 G540 G547
13. Floch M. H. Bile salts, intestinal microflora and enterohepatic circulation. Dig Liver Dis: 2002; 34 02 S54 S57
14. Usman H. A., Hosono A. Effect of administration of Lactobacillus gasseri on serum lipids and fecal steroids in hypercholesterolemic rats. J Dairy Sci: 2000; 83 8 1705 1711
15. Costalos C., Skouteri V., Gounaris A., et al. Enteral feeding of premature infants with Saccharomyces boulardii. Early Hum Dev: 2003; 74 2 89 96
16. American Academy of Pediatrics Subcommittee on Hyperbilirubinemia Management of hyperbilirubinemia in the newborn infant 35 or more weeks of gestation. Pediatrics: 2004; 114 1 297 316
17. Kaplan M., Merlob P., Regev R. Israel guidelines for the management of neonatal hyperbilirubinemia and prevention of kernicterus. J Perinatol: 2008; 28 6 389 397
18. Blackburn S. Hyperbilirubinemia and neonatal jaundice. Neonatal Netw: 1995; 14 7 15 25
19. Bin-Nun A., Bromiker R., Wilschanski M., et al. Oral probiotics prevent necrotizing enterocolitis in very low birth weight neonates. J Pediatr: 2005; 147 2 192 196
20. Deshpande G. C., Rao S. C., Keil A. D., Patole S. K. Evidence-based guidelines for use of probiotics in preterm neonates. BMC Med: 2011; 9 92
21. Wang W. J., Zheng Y. J. Clinical application of probotics in China. Chin J Microecol 2009-01
22. Liu L., Bao L. Y., Zhang L., Cui Y. L. The observation on effect of Clostridium butyricum powder in treatment of breast milk jaundice. Chin J Microecol: 2009; 21 3 260 261
23. Demirel G., Celik I. H., Erdeve O., Dilmen U. Impact of probiotics on the course of indirect hyperbilirubinemia and phototherapy duration in very low birth weight infants. J Matern Fetal Neonatal Med: 2013; 26 2 215 218
24. Serce O., Benzer D., Gursoy T., Karatekin G., Ovali F. Efficacy of saccharomyces boulardii on necrotizing enterocolitis or sepsis in very low birth weight infants: a randomised controlled trial. Early Hum Dev: 2013; 89 12 1033 1036
25. Ng E., Shah V. S. Erythromycin for the prevention and treatment of feeding intolerance in preterm infants. Cochrane Database Syst Rev: 2008; 16 3 CD001815